Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-09-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1277542/full |
| _version_ | 1797689833254027264 |
|---|---|
| author | Taiseer Al-Rajabi Jarushka Naidoo Jun Zhang Jun Zhang |
| author_facet | Taiseer Al-Rajabi Jarushka Naidoo Jun Zhang Jun Zhang |
| author_sort | Taiseer Al-Rajabi |
| collection | DOAJ |
| first_indexed | 2024-03-12T01:51:25Z |
| format | Article |
| id | doaj.art-90c561d66b774c26a35c334a6ae1996f |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-03-12T01:51:25Z |
| publishDate | 2023-09-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-90c561d66b774c26a35c334a6ae1996f2023-09-08T12:58:33ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-09-011310.3389/fonc.2023.12775421277542Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancerTaiseer Al-Rajabi0Jarushka Naidoo1Jun Zhang2Jun Zhang3University of Kansas, Lawrence, KS, United StatesSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, Baltimore, MD, United StatesDivision of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, United StatesDepartment of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, United Stateshttps://www.frontiersin.org/articles/10.3389/fonc.2023.1277542/fullimmune checkpoint inhibitorsimmunotherapynon-small cell lung cancer (NSCLC)immune related adverse effects (irAEs)cancer immunotherapy |
| spellingShingle | Taiseer Al-Rajabi Jarushka Naidoo Jun Zhang Jun Zhang Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer Frontiers in Oncology immune checkpoint inhibitors immunotherapy non-small cell lung cancer (NSCLC) immune related adverse effects (irAEs) cancer immunotherapy |
| title | Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer |
| title_full | Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer |
| title_fullStr | Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer |
| title_full_unstemmed | Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer |
| title_short | Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer |
| title_sort | editorial optimizing outcomes and addressing adversities of immunotherapy in lung cancer |
| topic | immune checkpoint inhibitors immunotherapy non-small cell lung cancer (NSCLC) immune related adverse effects (irAEs) cancer immunotherapy |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2023.1277542/full |
| work_keys_str_mv | AT taiseeralrajabi editorialoptimizingoutcomesandaddressingadversitiesofimmunotherapyinlungcancer AT jarushkanaidoo editorialoptimizingoutcomesandaddressingadversitiesofimmunotherapyinlungcancer AT junzhang editorialoptimizingoutcomesandaddressingadversitiesofimmunotherapyinlungcancer AT junzhang editorialoptimizingoutcomesandaddressingadversitiesofimmunotherapyinlungcancer |